HORIZON KINETICS ASSET MANAGEMENT LLC

Position in BEAM — Beam Therapeutics Inc.

CIK 1056823 NEW YORK, NY

Position in BEAM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$209,489

-$45,368 QoQ

Shares Held

8,791

-4.4% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HORIZON KINETICS ASSET MANAGEMENT LLC holds $19,937,430 across 14 Biotechnology names. BEAM ranks #6 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	340,783	$16,347,360
2	IONS	Ionis Pharmaceuticals Inc	11,428	$858,128
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,272	$751,736
4	REGN	Regeneron Pharmaceuticals, Inc.	675	$521,532
5	CRSP	CRISPR Therapeutics AG	9,796	$465,995
6	BEAM	Beam Therapeutics Inc. This page	8,791	$209,489
7	NTLA	Intellia Therapeutics, Inc.	13,188	$169,070
8	VNDA	Vanda Pharmaceuticals Inc.	23,736	$164,015

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$209,489	8,791	-4.4%	Shares	Defined	2026-05-15
2025-12-31	$254,857	9,194	-4.2%	Shares	Defined	2026-02-11
2025-09-30	$232,919	9,597	0.0%	Shares	Defined	2025-11-14
2024-12-31	$238,005	9,597	+4.4%	Shares	Defined	2025-02-10
2024-09-30	$225,253	9,194	-4.2%	Shares	Defined	2024-11-13
2024-06-30	$224,857	9,597	0.0%	Shares	Defined	2024-08-14
2024-03-31	$317,084	9,597	0.0%	Shares	Defined	2024-05-14
2023-12-31	$261,230	9,597	-4.0%	Shares	Defined	2024-02-15
2023-09-30	$240,500	10,000	0.0%	Shares	Defined	2023-11-14
2023-06-30	$319,300	10,000	0.0%	Shares	Defined	2023-08-14
2023-03-31	$306,200	10,000	—	Shares	Defined	2023-05-12
No filing history on record for this holder in this stock.